TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Shareholders’ equity 2023–2025
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) shareholders’ equity at each fiscal year-end, per SEC filings.
$245.2MFY2025 · since FY2023: $105.5M → $245.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $245.2M | +75.7% |
| FY2024 | $139.6M | +32.3% |
| FY2023 | $105.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice